Olwen Hahn to Transcriptome
This is a "connection" page, showing publications Olwen Hahn has written about Transcriptome.
Connection Strength
0.032
-
Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer. J Clin Oncol. 2020 12 10; 38(35):4184-4193.
Score: 0.032